12.14.20 | Menopause
Exploring the Impact of Menopause on Women’s Health
SWHR convened a diverse group of basic and clinical researchers, health care providers, patients/patient advocates, and thought leaders for a closed roundtable meeting to discuss the impact of menopause on women’s health.
12.8.20 | Policy
SWHR Urges Congress to Complete Work on FY21 Appropriations
SWHR signed onto a letter led by the American Society for Microbiology (ASM) and the American Association for the Advancement […]
12.8.20 | Policy
SWHR Urges President-Elect Biden to Prioritize NIH Funding
SWHR and nearly 350 other organizations signed onto a letter to President-Elect Biden discussing the importance of federal investment in […]
12.8.20 | Research and Clinical Trials
SWHR Supports FDA Recommendations to Include Younger Women in Breast Cancer Research
The Society for Women’s Health Research (SWHR) submitted comments in response to a newly released U.S. Food and Drug Administration […]
12.8.20 | Maternal Health
SWHR Calls for Congressional Approval of Maternal Health Bills
In a push to see maternal health bills included in a year-end legislative package, the Society for Women’s Health Research […]
12.3.20 | Coronavirus
SWHR Calls on Congress to Strengthen Public Health Funding in FY21 Budget
SWHR joined more than 75 organizations in calling for strong funding for government public health and biomedical research agencies for […]
12.2.20 | Endometriosis
SWHR Urges Congressional Leadership to Prioritize Endometriosis Research Funding
SWHR sent a letter to House and Senate leadership this week in support of endometriosis’ inclusion as an eligible condition […]
12.1.20 | Policy
A Call to Improve Women’s Eye Health Through Research, Access, and Education
Successfully improving women’s eye health requires attention to the continuum of health across the life span and awareness of these issues on a societal level.
11.23.20 | Research and Clinical Trials
SWHR Comments to FDA on MDUFA Reauthorization for Fiscal Years 2023-2027
The Society for Women’s Health Research (SWHR) submitted comments as a follow-up to the U.S. Food and Drug Administration (FDA) […]
10.16.20 | Alzheimer's Disease
SWHR Input to ICER on Assessment of New Alzheimer’s Disease Treatment
SWHR provided open input to the Institute for Clinical and Economic Review (ICER) on contextual considerations surrounding Alzheimer’s disease (AD) […]
